Department of Neurology, National institute of Mental Health and Neurosciences (NIMHANS, India - 560029), IN.
Neurosurgery, National institute of Mental Health and Neurosciences (NIMHANS, India - 560029), IN.
Tremor Other Hyperkinet Mov (N Y). 2022 Jun 20;12:22. doi: 10.5334/tohm.693. eCollection 2022.
Rare movement disorders (RMDs) throw remarkable challenges to their appropriate management particularly when they are medically refractory. We studied the outcome of functional neurosurgery among patients with RMDs.
Retrospective chart-review from 2006 to 2021 of patients with RMDs who underwent either Deep brain Stimulation (DBS) or lesional surgeries in the department of Neurology and Neurosurgery at a tertiary care centre.
Seventeen patients were included. Generalized dystonia (11 patients, 64.7%) and tremor (5 patients, 29.4%) were the most common indication for surgery whereas, Wilson's disease (8 patients, 47.1%) and Neurodegeneration with brain iron accumulation (5 patients, 29.4%) were the most common aetiology. Sixteen patients (94.1%) had objective clinical improvement. Significant improvement was noted in the dystonia motor scores both at 6-months and 12-months follow-up (n = 11, p-value of <0.01 and 0.01 respectively). Comparison between DBS and lesional surgery showed no significant difference in the outcomes (p = 0.95 at 6-months and p = 0.53 at 12-months), with slight worsening of scores in the DBS arm at 12-months. Among five patients of refractory tremor with Wilson's disease, there was remarkable improvement in the tremor scores by 85.0 ± 7.8% at the last follow-up. Speech impairment was the main complication observed with most of the other adverse events either transient or reversible.
Surgical options should be contemplated among patients with disabling medically refractory RMDs irrespective of the aetiology. Key to success lies in appropriate patient selection. In situations when DBS is not feasible, lesional surgeries can offer an excellent alternative with comparable efficacy and safety.
罕见运动障碍(RMD)对其管理提出了巨大挑战,尤其是当它们对药物治疗无反应时。我们研究了功能神经外科手术在 RMD 患者中的治疗效果。
对 2006 年至 2021 年间在一家三级保健中心的神经病学和神经外科部门接受深部脑刺激(DBS)或病灶性手术的 RMD 患者的病历进行回顾性分析。
共纳入 17 名患者。全身性肌张力障碍(11 例,64.7%)和震颤(5 例,29.4%)是手术最常见的指征,而威尔逊病(8 例,47.1%)和神经退行性脑铁沉积病(5 例,29.4%)是最常见的病因。16 名患者(94.1%)的临床症状有客观改善。在 6 个月和 12 个月的随访中,肌张力障碍运动评分均显著改善(n = 11,p 值分别为<0.01 和 0.01)。DBS 与病灶性手术的结果比较无显著差异(6 个月时 p = 0.95,12 个月时 p = 0.53),DBS 组在 12 个月时评分略有恶化。在 5 例对药物治疗无反应的震颤性威尔逊病患者中,震颤评分在末次随访时显著改善了 85.0±7.8%。言语障碍是最常见的并发症,大多数其他不良事件是短暂或可逆的。
对于药物难治性、致残性 RMD 患者,无论病因如何,都应考虑手术治疗。成功的关键在于正确选择患者。在 DBS 不可行的情况下,病灶性手术是一种疗效和安全性相当的替代方法。